000 | 00513nam a22001697a 4500 | ||
---|---|---|---|
005 | 20250711144949.0 | ||
008 | 250711b |||||||| |||| 00| 0 eng d | ||
020 | _a0812104005 | ||
041 | _aeng | ||
082 | _a615.7 S9C | ||
245 |
_aCurrent concept in the pharmaceutical science : _bdosage form design and bioavailability / _cedited by James Swarbrick. |
||
260 |
_aPhiladelphia: _bLea & Febiger, _c1973. |
||
300 | _axi, 230p. | ||
650 | _aBiopharmacuetics | ||
700 | _aSwarbrick, James. | ||
942 | _cBK | ||
999 |
_c127594 _d127594 |